Other stimulant abuse
ICD-10 F15.1 is a billable code used to indicate a diagnosis of other stimulant abuse.
F15.1 refers to the abuse of stimulants that are not classified under more specific stimulant categories, such as amphetamines or cocaine. This includes substances like methamphetamine, ecstasy (MDMA), and other synthetic stimulants. Individuals with stimulant abuse may exhibit a range of symptoms including increased energy, euphoria, and heightened alertness, but can also experience negative effects such as anxiety, paranoia, and cardiovascular issues. The diagnosis of stimulant abuse is characterized by a pattern of use leading to significant impairment or distress, including failure to fulfill major role obligations, recurrent legal problems, and continued use despite social or interpersonal problems. Withdrawal symptoms can occur when the substance is reduced or discontinued, manifesting as fatigue, depression, and increased appetite. Treatment typically involves behavioral therapies, counseling, and support groups, as there are currently no FDA-approved medications specifically for stimulant use disorder. Comprehensive treatment programs may also address co-occurring mental health disorders, which are common in individuals with stimulant abuse.
Detailed history of substance use, including frequency, quantity, and context of use.
Patients presenting with withdrawal symptoms, seeking detoxification, or requiring rehabilitation.
Consideration of co-occurring mental health disorders and comprehensive treatment planning.
Thorough psychiatric evaluation, including mental status examination and assessment of comorbid conditions.
Patients with anxiety, depression, or psychosis related to stimulant use.
Documentation of any psychiatric interventions or medications prescribed.
Used when assessing a patient for substance use disorder.
Complete assessment report detailing substance use history and current status.
Addiction specialists should ensure comprehensive evaluations are conducted.
F15.1 includes various stimulants not specifically classified, such as methamphetamine, MDMA, and other synthetic stimulants. It is important to document the specific substance used for accurate coding.
